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Abstract. The interaction between the quercetin (a generic flavonoid molecule) and the ligand 
binding domain of the peroxisome proliferator–activated receptor-gamma was investigated using the 
AutoDock software, which allows docking of molecular ligands to receptor macromolecules. 
AutoDock is able to find the most favourable binding site for quercetin on the receptor ligand binding 
domain and to predict the binding mode. The results show that the bonding is mainly driven through 
hydrogen bond type interactions and suggest the existence of two favourable quercetin conformations 
which coexist. 
 




The peroxisome proliferator-activated receptors (PPARs) are a class of nuclear 
receptors. The interest in the PPARs originates from the fact that they are key regulators in 
adipocyte differentiation, and in lipid and glucose metabolism (Desvergne et al., 2004; 
Ehrmann et al., 2002). 
As opposed to signalling molecules that function as ligands for transmembrane 
receptors (i.e. polypeptidic hormones) and exert their action by binding to the receptors and 
then inducing a cascade of intracellular biological responses, the ligands for nuclear receptors 
(i.e. steroid hormones) act directly on the nucleus and signal transduction takes place without 
intermediates (Socaciu, 1996). More precisely, the ligand binding to a nuclear receptor 
activates the receptor, which then has the ability to directly bind to DNA and regulate gene 
expression (up- or down-regulation of gene expression), reason for which they are called 
transcription factors.  
Three PPARs subtypes have been identified in mammals: PPAR-α, PPAR-γ, and 
PPAR-δ (known as PPAR-β) (Ehrmann et al.). Common ligands for PPARs are saturated and 
unsaturated fatty acids and fatty acid metabolites (Ehrmann et al., 2002; Kasuga et al., 2007), 
as well as synthetic ligands. For example, the PPAR-γ is commonly used as target for the 
treatment of type 2 diabetes mellitus (Goldstein, 2008). This receptor is expressed in tissues 
where insulin exerts its action: adipocytes, myocytes, but also macrophages and vascular 
smooth muscles and plays a key role in the process of insulin sensitisation (Goldstein, 2008; 
Nunn et al., 2007). The antidiabetic drugs from the thiazolidinediones class (i.e. pioglitazone, 
rosiglitazone) are ligands that exert their effect by binding to the peroxisome proliferator-
activated receptor-γ (PPAR-γ receptor) and activating the receptor. The activation of PPAR-γ 
results in a reduction of plasma non esterified free fatty acids (fat redistribution from liver and 
muscle cells towards adipose tissue cells), leading to improved muscle insulin sensitivity and 
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insulin signalling by increasing the insulin-stimulated GLUT4 receptor activity and muscle 
glycogen synthesis (Petersen et al., 2006).  
In the present study quercetin will be investigated as potential ligand for the PPAR-γ 
receptor. The focus will be on modeling the interaction between the ligand quercetin (Fig. 
1(a)) and the ligand binding domain (LBD) of the PPAR-γ receptor (Fig. 2) using the 
molecular docking AutoDock software. Identifying new small molecule ligands for PPAR-γ is 
a research area of interest which may have an impact on the management and treatment of 
type 2 diabetes mellitus. 
(a) (b) 
Fig. 1. Molecular structures of the (a) quercetin and (b) rutin molecules. 
 (a) 
 (b) 
Fig. 2. (a) Ribbon representation of the 3D crystal structure of the LBD of PPAR-γ (the LBD is formed of the 
amino acid residues 207-476 of the receptor), pdb code 1PRG (http://www.pdb.org/pdb). The structure is 
formed of α-helices, β-strands, and loops. (b) Alternative representation of the PPAR-γ LBD (molecular 
surface representation).  
 
The interest in quercetin stems from the fact that it is the aglycone part of the rutin 
molecule, which is mentioned in literature as a potential antidiabetic compound 
(http://www.ars-grin.gov/duke/; Ahmed et al., 2010; Kamalakkannan et al., 2006; Fernandez 
et al., 2010). Rutin (quercetin-3-O-rutinoside) is a flavonoid molecule, formed of quercetin 
and rutinose (β-D-glucose and α-L-rhamnose) moieties (Fig. 1(b)), as the name suggests. 
According to literature (Pashikanti et al., 2010), rutin is not absorbed intact by the body, but it 
is metabolised in the intestine to quercetin and phenol derivatives, which implies that the 
potential antidiabetic effect is caused by the metabolites rather than rutin itself. The 
mechanism of action of rutin is not entirely understood. A recent experimental study (Ahmed 
et al., 2010) links its hypoglycaemic effect of rutin on nicotinamide-streptozotocin-induced 
diabetic rats with increased expression of the PPAR-γ receptor. For this reason, the present 
work aims at modeling the interaction between quercetin and the LBD of the PPAR-γ. The 
LBD is the active part of the any macromolecule, where any ligand is expected to bind.  
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Molecular docking is a very important tool, specially in computer-aided drug design. 
The AutoDock software (http://autodock.scripps.edu/) is a suite of programs that makes it 
possible to perform protein-ligand docking, more precisely it allows predicting how the two 
molecules interact, which is the prefered orientation of the ligand molecule with respect to the 
receptor, the type and strenghth of the bonding. It is particularly useful to predict how small 
molecule, potential drug candidates bind to receptors of known structure. 
 
MATERIALS AND METHODS 
 
The molecular docking calculations were conducted using the AutoDock software 
version 4.2 (Morris et al., 2009). The AutoDock 4.2 used for the present study consists of two 
programs: AutoGrid which pre-calculates some grid maps which are used for describing the 
target protein or the target binding site in the protein molecule, and AutoDock which 
performs the actual docking simulation of the ligand to these grids. In order to setup the 
molecules for docking, to run the actual docking calculations, and also to visualise the 
docking results, a graphical user interface called AutoDock Tools (ADT) is used (Sanner et 
al., 1999).  
AutoDock performs calculations on molecules with known structures. Normally, the 
receptor structures are experimentally determined by x-ray crystallography and can be 
imported from international validated databases. The 3D molecular structure of the LBD of 
PPAR-γ was obtained from the Protein Data Bank [http://www.pdb.org] (pdb code 1PRG), 
while the quercetin molecular structure was generated by using the Chem Office soft 
(http://scistore.cambridgesoft.com/chemoffice). The 1PRG molecule is a dimer build up of 
two chains A and B, each consisting of 270 amino acid sequences (residues 207-476 of the 
whole PPAR-γ receptor) (Nolte et al., 1998). For the calculations, the B chain of the dimer 
was deleted from the 1PRG structure, in order to have only one possible active binding site 
for the quercetin molecule. 
Prior to docking, the correct input files needed to run the AutoGrid and AutoDock 
calculations are set up using the ADT graphical user interface. These preparations refer to: 
removing any water and solvent molecules present in the original Protein Data Bank files, 
merging non-polar hydrogens (only polar hydrogens are used by AutoDock), adding 
Gasteiger charges, choosing the active torsions in the ligand molecule, assigning atom types 
in the ligand molecule, setting up the grid parameter files and docking parameter files. A rigid 
receptor was used for the calculatins and for the quercetin ligand the number of free torsions 
was six (all possible six active torsions were allowed to move). 
The affinity grid maps were generated by using the auxiliary program AutoGrid. 
Because the binding site for quercetin is not known, the calculations were performed in two 
consecutive steps. First, in an initial calculation the grid box size was set 126x126x126 points 
with 0.375 Å separation in between the grid poins, which covers almost all the surface of the 
PPAR-γ LBD. In this initial experiment the macromolecule and the ligand are placed in 
random positions; when the docking job starts AutoDock places the ligand inside the volume 
of the grid box and finds the most favourable binding site in the receptor. Once the prefered 
binding site was identified, in a second step more refined calculations were carrried out, by 
changing the initial quercetin ligand coordinates with those of the lowest energy conformation 
found in the initial AutoDock run. This time a grid box of 60x60x60 points, centered on the 
ligand,  with 0.375 Å distance in between the points was used. 
The Autodock simulations were carried out using the Lamarckian Genetic Algoritm 
(Morris et al., 1998). Default parameters were used, except for the number of energy 
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evaluations and the number of trials. The number of GA runs (genetic algoritm runs) was set 
to 100, and different docking calculations were carried out with the maximum number of 
energy evaluations of 250.000, 2.500.000, and 10.000.000 respectively. The resulting docked 
quercetin conformations were clustered into groups of similar binding modes, with a root 
mean square deviation (rmsd) of 2.0 Å.  
 
RESULTS AND DISCUSSION 
 
The AutoDock job is composed of several runs or trials (GA runs). For each run there is a 
maximum number of energy evaluations that is performed. After each docking run, AutoDock 
gives ligand lowest enegy conformation it finds after performing the run. The cartesian 
coordinates and different energy values are given as output. At the end of the job, several 
conformations are calculated, depending on the number of docking runs. The conformations 
are grouped in clusters, according to their similarity to each other. The similarity is measured 
in terms of root mean square deviation between the coordinates of the different atoms in the 
ligand. The clustering results obtained for the different autodock jobs performed in this study, 
at an rms value of 2.0 Å, are shown in Fig. 3. The clustering improves with the number of 
energy evaluations (see also Fig. 4); the best clustering was obtained for the most refined job 








Fig. 3. Representation of the clustering results (rms=2.0 Å) obtained for AutoDock jobs using improved number 
of energy evaluations: (a) 250.000, (b) 2.500.000, and (c) 10.000.000 evaluations.  
 
Fig. 4. Representation of the influence that the number 
of energy evaluations used for each docking run has on 
the total fraction of conformations that give correct 
results (considered as the sum of populations of cluster 
A and cluster B).  
 
There are two cluters (labelled A and B) grouping quercetin conformations of around -
7.5 kcal/mole and -7.2 kcal/mole binding energies, which for the best docking of 10.000.000 
evaluations have roughly the same population (no. of conformations from each cluster) of 
41% A and 42 % B. Normally, the best docking result is the configuration with lowest energy, 
which is the most stable configuration and which si expected to have the highest population. 
In the particular case here considered of rutin-PPAR-γ LBD docking, it is concluded that 
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since the A and B clusters have very similar populations, actually two conformations giving 
rise to the clusters are both favourable conformations. Since they are close in binding energy, 
it is likely that both conformations are energetically allowed. Representative docking 
parameters for the two clusters are shown in Tab. 1.  
 
 
Representative docking results obtained for the quercetin-PPAR-γ LBD system. The 
binding enegies and docking energies (Ebinding and Edocking) are given for the lowest energy 
configuration in each cluster. The binding energy is defined as the sum of intermolecular and 
torsional energies, and the docking energy is given by the sum of intermolecular and internal 















250.000 100 -7.49 -10.50 28 24m35s 
2.500.000 100 -7.49 -10.47 38 4h03m46s 
 
A 
10.000.000 100 -7.50 -10.52 41 16h20m25s 
250.000 100 -7.00 -9.86 42 24m35s 
2.500.000 100 -7.22 -10.04 38 4h03m46s 
B 
10.000.000 100 -7.22 -10.01 42 16h20m25s 
  
 In the following paragraphs, the lowest energy conformations from the A and B 
clusters will be named configuration A and configuration B and the discussion will focus on 
the results obtained for the 100 GA runs and 10.000.000 energy evaluations docking since it 
is the one that gives best results. In Fig. 5 the receptor-ligand complex for both quercetin 
configurations is illustrated, as well as their relative orientation to eachother. As can be seen 










Fig. 5. The quercetin-PPAR-γ LBD complex for (a) conformation A and (b) conformation B, as resulted from the 
AutoDock calculations; (c) the relative orientations of conformations A and B rotated with respect to what is 
shown in panels (a) and (b), for a better view of the structures. 
 
 209 
 The quercetin-PPAR-γ LBD interaction is mostly driven by hydrogen bonds: the 
intermolecular energy term that accounts for van der Waals and hydrogen bond type 
interactions weights more than 90% of the total intermolecular interaction (94.3% for 
conformation A and 91% for conformation B), as oposed to the electrostatic term which is 
below 10%. Five hydrogen bonds are formed in between hydroxyl groups of quercetin in 
conformation A and amino acid residues in the receptor, while conformation B interacts by 
four hydrogen bonds (Tab. 2 and Fig. 6).  
 
The hydrogen bonds formed in between the quercetin molecule and the LBD of the 
PPAR-γ receptor, as resulted from the AutoDock calculations. The H bond donor is 
considered the molecule which donates the proton, while the H bond acceptor is the molecule 
containing the electronegative element. 
 Tab. 2 
 
Conformation A Conformation B 
H bond donor H bond acceptor H bond donor H bond acceptor 
QUE (H) GLU291 (O1) SER342 (NH) QUE (O) 
SER342 (NH) QUE (O) LEU228 (NH) QUE (O) 
LEU228 (NH) QUE (O) QUE (H) GLU291 (O2) 
QUE (H) MET329 (O) GLU343 (NH) QUE (O) 
QUE (H) GLU291 (O2)   
  
Fig. 6. Ilustration of the hydrogen bonds formed between the quercetin molecule and the LBD of the PPARγ 
receptor (a) binding mode for configuration A and (b) binding mode for configuration B. 
 
 The amino acid residues of the receptor involved in the interaction with conformation 
A are the SER342 LEU228, MET329, and GLU291, while conformation B interact with 
SER342, LEU228, GLU291, and GLU343. More precisely, with conformation A the GLU291 
residue forms two H bonds in which it acts as H bond acceptor, MET329 one bond as 
acceptor, SER342 and LEU228 form each one bond as donors. On the other hand GLU291 
forms only one H bond with conformation B, and SER342, LEU228 and GLU343 form the 





By using the AutoDock software it was possible to investigate the interaction between 
quercetin as ligand and the LBD of the PPAR-γ receptor. The influence of improving the 
docking parameters (the number of energy evaluations per docking run) on the quality of final 
results, especially on the clustering was also tested. Two favourable quercetin conformations 
of close energies, named conformations A and B were reported in the present study. Quercetin 
binds to PPAR-γ by hydrogen bond type interactions; conformation A forms five hydrogen 
bonds with the receptor, while conformation B forms four hydrogen bonds. Since the exact 
mechanism of action of the hypoglycaemic flavonoid rutin is not yet understood and since it 
is believed that it exerts the action through metabolites such as quercetin, the present study is 
of particular interest. In the future more work will be carried out by performing more 
extensive calculations in order to try to find out if any of the two most stable conformations 
becomes predominant. 
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